Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant. 2015.
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties. Bone Marrow Transplant. 2015.
Tolerability and Clinical Activity of Post-transplant Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA trial. Biol Blood Marrow Transplant. 2015.